Companies
European Biotech Sector Growing Quicker Than US Counterpart
January 2007 | Industry NewsGrowth of the global biotechnology sector is expected to exceed that of the pharmaceutical industry significantly over the next five years. Currently, 83% and of pharmaceutical sales are from small-molecules and 15% from biologicals. But, by 2010, only 76% of sales will be from small-molecules and 22% from biologicals. At that time, the global biotechnology market will be worth just over US$100bn - a 70% increase on 2005 sales
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
